We operate through
a global network of senior
regulatory experts.
EARLY DEVELOPMENT & INNOVATION
Building Strong Foundations for Future Success
The most important regulatory decisions are often made long before the first marketing authorisation application is prepared. Early development activities shape future clinical programs, regulatory pathways, investment decisions, and ultimately the likelihood of successful registration.
A-REG supports biotechnology companies, vaccine developers, university spin-offs, and innovative pharmaceutical organisations in translating scientific concepts into practical regulatory strategies and development roadmaps.
Development Strategy & Regulatory Pathways
Successful development programs begin with a clear understanding of the desired destination and the most appropriate path to reach it. By aligning scientific, regulatory, and commercial considerations early, we help clients make informed decisions and reduce future development risks across global markets.
Focus areas:
- Target Product Profile (TPP) development/review
- Indication(s) prioritization & global development strategy
- Regulatory pathways evaluation
- Registration(s) planning including reliance opportunities assessment
Innovation, Incentives
& Health Authority Engagement
Innovative products often benefit from early interactions with regulators and from development incentives designed to support promising therapies. We help clients identify and evaluate opportunities such as Scientific Advice, orphan designation programs, pediatric incentives, accelerated pathways, and other regulatory mechanisms that may support efficient development up to registration and commercial phase.
Focus areas:
- Early Health Authority interactions including
- Scientific Advice strategy
- Orphan designation, Pediatric planning and PIP considerations
- Accelerated development pathways
- Regulatory incentives assessment
From Science to Investment Readiness
For emerging biotechnology companies and university spin-offs, regulatory strategy is often closely linked to fundraising, partnerships, and future business growth. We help organisations translate scientific innovation into clear development roadmaps, providing structure, rationale, and regulatory clarity that support discussions with investors, partners, and Health Authorities alike.
Focus areas:
- Development roadmaps
- Regulatory risk assessments & due diligence support
- Strategic decision frameworks
- Investor support & partnership readiness
VACCINES & BIOLOGICS
Expertise Across Complex
Development Programs
Vaccines and biologics present unique scientific, manufacturing, and regulatory challenges throughout their lifecycle. Drawing on extensive experience with innovative and established products, A-REG supports organisations from early development through registration, global expansion, and lifecycle management. Our expertise combines strategic thinking with practical execution across some of the most complex regulatory environments worldwide.
Vaccines, Adjuvants & Platform Technologies
Our experience includes traditional and innovative vaccine approaches, adjuvanted products, and platform-based development strategies. We help clients build regulatory frameworks that support both individual products and future portfolio development.
Focus areas:
- Vaccine development programs
- Adjuvant strategy
- Platform technologies
- Prior knowledge and data leverage
Monoclonal Antibodies & Advanced Biologics
Biological products often require specialised approaches to development, comparability, manufacturing changes, analytical strategies, and lifecycle planning. We support organisations developing innovative biologics by helping navigate the complexity inherent to these products throughout development and commercialisation.
Focus areas:
- Monoclonal antibodies
- Recombinant proteins
- Comparability strategies & biosimilar considerations
- CMC development and product characterisation
Complex Manufacturing & Product Lifecycle
Unlike many small-molecule products, vaccines and biologics are closely linked to their manufacturing processes. Product changes, manufacturing site transfers, testing strategies, supply chain considerations, and lifecycle activities often require careful planning to maintain regulatory compliance and long-term commercial viability.
Focus areas:
- Manufacturing changes & technology transfers
- Batch release strategies
- Global supply considerations
- Lifecycle optimisation
CMC & PLATFORM
STRATEGIES
Building Sustainable Foundations for Development and Commercialisation
Regulatory success depends not only on clinical evidence, but also on the robustness of manufacturing processes, product architecture, and lifecycle planning. Early CMC decisions can significantly influence development timelines, regulatory pathways, manufacturing flexibility, and future commercial opportunities.
CMC Development & Regulatory Architecture
Well-designed CMC programs help reduce uncertainty and support efficient development and registration. We help clients identify critical priorities, assess development needs, and establish regulatory frameworks aligned with both immediate goals and future lifecycle plans.
Focus areas:
- CMC development and control strategy considerations
- CTD architecture and dossier structuring
- Product presentation strategy
- Regulatory expectations mapping
Platform Technologies & Future Portfolio Planning
Shared technology platforms can create significant efficiencies when supported by an appropriate regulatory framework. We help clients leverage prior knowledge, align development efforts across programs, and build sustainable strategies for future portfolio growth.
Focus areas:
- Platform technology strategy and frameworks
- Data leverage and prior knowledge
- Cross-program regulatory planning
- Master File and Platform Master File approaches
Manufacturing Networks & Lifecycle Robustness
Manufacturing networks, testing laboratories, supply chains, and batch release strategies often evolve throughout the product lifecycle. We help clients balance regulatory requirements with operational efficiency while maintaining long-term flexibility.
Focus areas:
- Manufacturing network strategies
- Analytical testing frameworks
- Batch release and supply chain flexibility considerations
- Lifecycle optimisation
Comparability & Change Management
Product improvements, manufacturing changes, site transfers, and presentation updates require careful planning to maintain compliance and minimise regulatory risk. We help clients develop practical approaches that support both innovation and continuity.
Focus areas:
- Comparability strategies
- Manufacturing changes, process improvements and site transfers
- Change management planning
HEALTH AUTHORITY ENGAGEMENT
Building Alignment Before Critical Decisions Are Made
Successful regulatory interactions are rarely defined by a single meeting or submission. They are built through strategic preparation, clear communication, understanding of Health Authority expectations, and timely engagement throughout product development and lifecycle management.
Strategic Health Authority Interactions
We support organisations in preparing for complex regulatory discussions, helping translate scientific, clinical, and CMC topics into clear and effective communication with Health Authorities.
Focus areas:
- Scientific Advice and protocol assistance
- Pre-submission interactions
- Meeting preparation and moderation
Regulatory Negotiations & Strategic Positioning
Complex products and development programs often require thoughtful justification and discussion of alternative approaches. We help clients build evidence-based positions, structure argumentation architecture and communicate effectively to regulators.
Focus areas:
- Strategic argumentation
- Position papers and briefing packages
- Regulatory flexibility discussions
- Stakeholder alignment and consensus building
Multi-Agency & Global Coordination
Many development programs involve multiple Health Authorities operating across different regions and regulatory frameworks. We help clients align messaging, expectations, and development plans while maintaining a coherent global regulatory approach.
Focus areas:
- Cross-regional Health Authority coordination
- EMA, MHRA, WHO and international agencies
- Reliance and reference authority frameworks
GLOBAL ACCESS
& REGULATORY RELIANCE
Turning Regulatory Success into Market Expansion
For many organisations, regulatory approval in one market represents only the beginning of the journey. Reliance and recognition pathways increasingly allow companies to leverage existing approvals and assessments to support registrations in additional regions.
Drawing on experience across reliance frameworks, multi-region registration programs, and WHO pathways, we help clients develop practical strategies for expanding access while maintaining an aligned global regulatory position.
Focus areas:
- Global registration sequencing
- WHO and reference authority frameworks
- Dossier alignment and harmonisation
- Market expansion strategies
- Multi-region lifecycle planning